Broad-spectrum human papillomavirus vaccines: new horizons but one step at a time.
Bosch
F Xavier
FX
D052685:Alphapapillomavirus / Q000276:immunology; D000818:Animals; D017321:Clinical Trials, Phase I as Topic; D017326:Clinical Trials, Phase III as Topic; D005260:Female; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D008403:Mass Screening; D030361:Papillomavirus Infections / Q000150:complications / Q000517:prevention & control* / Q000821:virology; D053918:Papillomavirus Vaccines / Q000276:immunology / Q000627:therapeutic use*; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control* / Q000821:virology*; D014625:Vaginal Neoplasms / Q000517:prevention & control / Q000821:virology; D014846:Vulvar Neoplasms / Q000517:prevention & control / Q000821:virology
D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines; C510352:human papillomavirus vaccine, L1 type 16, 18